CAR‐NK, a Splendid Strategy for Cancer, Especially for Gynecologic Tumor
ABSTRACT Background NK cells are a class of innate lymphocytes capable of nonspecifically killing tumor cells without MHC restriction or prior sensitization. Recent advancements in biotechnology, particularly the development of chimeric antigen receptors (CAR) and related technologies, have enabled...
Saved in:
Main Authors: | Yisen Cao, Liying Wang, Liang Wang |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2025-06-01
|
Series: | Immunity, Inflammation and Disease |
Subjects: | |
Online Access: | https://doi.org/10.1002/iid3.70210 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Does a natural killer need a CAR?
by: Kangbo Wang, et al.
Published: (2025-06-01) -
The use of T-cells with chimeric antigen receptor (CAR-T) in combination with chemotherapy and radiotherapy for the treatment of solid tumors
by: M. R. Khaliulin, et al.
Published: (2024-04-01) -
From spheroids to organoids: next-generation models for CAR-T cell therapy research in solid tumors
by: Mégane Jassin, et al.
Published: (2025-07-01) -
Research progress on chimeric antigen receptor-based immunotherapy against autoimmune diseases
by: Mingwei Jiang, et al.
Published: (2025-12-01) -
CAR-T: from bench to bedside
by: M. О. Popova, et al.
Published: (2024-09-01)